Kaveri Pohlman

Stock Analyst at Clear Street

(0.47)
# 4,122
Out of 5,017 analysts
25
Total ratings
25%
Success rate
-25.72%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Kaveri Pohlman

Ventyx Biosciences
Oct 1, 2025
Initiates: Buy
Price Target: $11
Current: $3.56
Upside: +208.99%
RAPT Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $24$41
Current: $26.79
Upside: +53.04%
Oruka Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $24.49
Upside: +87.83%
ArriVent BioPharma
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $20.89
Upside: +53.22%
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.69
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46$47
Current: $31.81
Upside: +47.75%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20$30
Current: $7.40
Upside: +305.41%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56$38
Current: $13.03
Upside: +191.63%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $3.74
Upside: +33.69%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $26.51
Upside: +133.87%
Initiates: Buy
Price Target: $8
Current: $3.70
Upside: +116.22%
Initiates: Buy
Price Target: $27
Current: $38.15
Upside: -29.23%
Reiterates: Buy
Price Target: $70
Current: $14.60
Upside: +379.45%
Initiates: Buy
Price Target: $12
Current: $1.84
Upside: +552.17%
Maintains: Buy
Price Target: $16$8
Current: $3.36
Upside: +138.10%
Maintains: Buy
Price Target: $12,320$4,928
Current: $4.41
Upside: +111,646.03%